Lanzamiento Enero 2027

Ensayo controlado aleatorizado2015Acceso abierto

Topical olive oil is not inferior to hyperoxygenated fatty aids to prevent pressure ulcers in high-risk immobilised patients in home care. Results of a multicentre randomised triple-blind controlled non-inferiority trial

Lupiañez-Perez I, Uttumchandani SK, Morilla-Herrera JC, Martin-Santos FJ, Fernandez-Gallego MC, Navarro-Moya FJ, Lupiañez-Perez Y, Contreras-Fernandez E, Morales-Asencio JM

PloS one · 21 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Ministerio de Sanidad, Política Social e Igualdad

Según 1 financiador declarado y la declaración de financiación del texto completo.

Publicación

Publicado
2015-04-17 · PLoS One · vol. 10 · número 4 · pág. e0122238
Editorial
Public Library of Science
Citado
33 citas · más que el 94% de estudios similares · 4.9× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
37 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Pressure Ulcer Prevention and Management · Wound Healing and Treatments · Neonatal skin health care
Palabras clave
pressure ulcer prevention, home care, non-inferiority, sacrum, heel, trochanter, skin care products, primary care, pressure ulcer incidence, extra virgin olive oil, non-pharmacological prevention, Andalusia
MeSH
heel, femur, sacrum, humans, fatty acids, treatment outcome, follow-up studies, immobilization, aged, aged, 80 and over, middle aged, caregivers, patients, home care services, primary health care, pressure ulcer, female, male, olive oil

9 autores

  • Inmaculada Lupiáñez‐Pérez🇪🇸 · autor de correspondenciaAndalusian Health Service
  • Shakira Kaknani‐Uttumchandani🇪🇸Universidad de Málaga
  • Juan Carlos Morilla Herrera🇪🇸Andalusian Health Service
  • Francisco Javier Martín‐Santos🇪🇸Andalusian Health Service
  • Magdalena Cuevas Fernández‐Gallego🇪🇸Andalusian Health Service
  • Francisco Javier Navarro-Moya🇪🇸Andalusian Health Service
  • Yolanda Lupiañez-Perez🇪🇸Andalusian Health Service; Hospital Clínico Universitario Virgen de la Victoria
  • Eugenio Contreras-Fernández🇪🇸Andalusian Health Service
  • José Miguel Morales‐Asencio🇪🇸Universidad de Málaga

Resumen

El texto original del estudio, en el idioma en que se publicó.

Unlabelled

Pressure ulcers represent a major current health problem and produce an important economic impact on the healthcare system. Most of studies to prevent pressure ulcers have been carried out in hospital contexts, with respect to the use of hyperoxygenated fatty acids and to date, no studies have specifically examined the use of olive oil-based substances.

Methods and design

Main objective: To assess the effectiveness of the use of olive oil, comparing it with hyperoxygenated fatty acids, for immobilised home-care patients at risk of suffering pressure ulcers. Design: Non-inferiority, triple-blind, parallel, multicentre, randomised clinical trial. Scope: Population attending Primary Healthcare Centres in Andalusia (Spain). Sample: 831 immobilised patients at risk of suffering pressure ulcers.

Results

The follow-up period was 16 weeks. Groups were similar after randomization. In the per protocol analysis, none of the body areas evaluated presented risk differences for pressure ulcers incidence that exceeded the 10% delta value established. Sacrum: Olive Oil 8 (2.55%) vs HOFA 8 (3.08%), ARR 0.53 (-2.2 to 3.26) Right heel: Olive Oil 4 (1.27%) vs HOFA 5 (1.92)%, ARR0.65 (-1.43 to 2.73). Left heel: Olive Oil 3 (0.96%) vs HOFA 3 (1.15%), ARR0.2 (-1.49 to 1.88). Right trochanter: Olive Oil 0 (0%) vs HOFA 4 (1.54%), ARR1.54 (0.04 to 3.03). Left trochanter: Olive Oil 1 (0.32%) vs HOFA 1 (0.38%), ARR0.07 (-0.91 to 1.04). In the intention to treat analysis the lower limit of the established confidence interval was never exceeded.

Discussion

The results obtained confirmed that the use of topical extra-virgin olive oil to prevent PU in the home environment, for immobilised patients at high risk, is not inferior to the use of HOFA. Further studies are needed to investigate the mechanism by which olive oil achieves this outcome.

Trial registration

Clinicaltrials.gov NCT01595347.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.